Amyloid beta-Peptides; Alzheimer Disease/pathology; Amyloid beta-Peptides/metabolism; Animals; Brain/pathology; Disease Models, Animal; Drosophila; Humans; Mice; Mice, Transgenic; Models, Biological; Phosphorylation; Protein Denaturation; Alzheimer's disease; amyloid β; oligomers; posttranslational modification; protein folding; Neuroscience (all); Molecular Biology; Biochemistry, Genetics and Molecular Biology (all); Immunology and Microbiology (all); amyloid beta; post-translational modification; General Immunology and Microbiology; General Biochemistry, Genetics and Molecular Biology; General Neuroscience
Abstract :
[en] Alzheimer's disease (AD) is the most common form of dementia and associated with progressive deposition of amyloid β-peptides (Aβ) in the brain. Aβ derives by sequential proteolytic processing of the amyloid precursor protein by β- and γ-secretases. Rare mutations that lead to amino-acid substitutions within or close to the Aβ domain promote the formation of neurotoxic Aβ assemblies and can cause early-onset AD. However, mechanisms that increase the aggregation of wild-type Aβ and cause the much more common sporadic forms of AD are largely unknown. Here, we show that extracellular Aβ undergoes phosphorylation by protein kinases at the cell surface and in cerebrospinal fluid of the human brain. Phosphorylation of serine residue 8 promotes formation of oligomeric Aβ assemblies that represent nuclei for fibrillization. Phosphorylated Aβ was detected in the brains of transgenic mice and human AD brains and showed increased toxicity in Drosophila models as compared with non-phosphorylated Aβ. Phosphorylation of Aβ could represent an important molecular mechanism in the pathogenesis of the most common sporadic form of AD.
Disciplines :
Neurology
Author, co-author :
Kumar, Sathish; Department of Neurology, University of Bonn, Bonn, Germany
Rezaei-Ghaleh, Nasrollah; Department for NMR-based Structural Biology, Max-Planck-Institute for Biophysical Chemistry, Göttingen, Germany
Terwel, Dick; Department of Neurology, University of Bonn, Molecular Cell Biology, 53127 Bonn, Germany
Thal, Dietmar R; Department of Pathology, University of Ulm, Ulm, Germany
Richard, Mélisande; Department of Molecular Developmental Biology, LIMES Institute, University of Bonn, Bonn, Germany
Hoch, Michael; Department of Molecular Developmental Biology, LIMES Institute, University of Bonn, Bonn, Germany
Mc Donald, Jessica M; Laboratory for Neurodegenerative Research, University College Dublin, Dublin 4, Ireland
Wüllner, Ullrich; Department of Neurology, University of Bonn, Molecular Cell Biology, 53127 Bonn, Germany
Glebov, Konstantin; Department of Neurology, University of Bonn, Molecular Cell Biology, 53127 Bonn, Germany
HENEKA, Michael ; Department of Neurology, University of Bonn, Molecular Cell Biology, 53127 Bonn, Germany
Walsh, Dominic M; Laboratory for Neurodegenerative Research, University College Dublin, Dublin 4, Ireland
Zweckstetter, Markus; Department for NMR-based Structural Biology, Max-Planck-Institute for Biophysical Chemistry, Göttingen, Germany ; DFG Research Center for the Molecular Physiology of the Brain (CMPB), Göttingen, Germany
Walter, Jochen; Department of Neurology, University of Bonn, Molecular Cell Biology, 53127 Bonn, Germany
Bilen J, Bonini NM (2005) Drosophila as a model for human neurodegenerative disease. Annu Rev Genet 39: 153-171 (Pubitemid 43011111)
Chen W, Wieraszko A, Hogan MV, Yang HA, Kornecki E, Ehrlich YH (1996) Surface protein phosphorylation by ecto-protein kinase is required for the maintenance of hippocampal long-term potentia-tion. Proc Natl Acad Sci USA 93: 8688-8693 (Pubitemid 26269621)
Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333-366 (Pubitemid 44118036)
Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM (2003) Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424: 805-808 (Pubitemid 37021713)
Cho YS, Lee YN, Cho-Chung YS (2000a) Biochemical characteriza-tion of extracellular cAMP-dependent protein kinase as a tumor marker. Biochem Biophys Res Commun 278: 679-684
Cho YS, Park YG, Lee YN, Kim MK, Bates S, Tan L, Cho-Chung YS (2000b) Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression. Proc Natl Acad Sci USA 97: 835-840 (Pubitemid 30070396)
Crowther DC, Kinghorn KJ, Miranda E, Page R, Curry JA, Duthie FA, Gubb DC, Lomas DA (2005) Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 132: 123-135 (Pubitemid 40380720)
Crystal AS, Giasson BI, Crowe A, Kung MP, Zhuang ZP, Trojanowski JQ, Lee VM (2003) A comparison of amyloid fibril-logenesis using the novel fluorescent compound K114. J Neurochem 86: 1359-1368 (Pubitemid 37174253)
Di FG, Catania M, Morbin M, Rossi G, Suardi S, Mazzoleni G, Merlin M, Giovagnoli AR, Prioni S, Erbetta A, Falcone C, Gobbi M, Colombo L, Bastone A, Beeg M, Manzoni C, Francescucci B, Spagnoli A, Cantu L, Del FE et al (2009) A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 323: 1473-1477
Finelli A, Kelkar A, Song HJ, Yang H, Konsolaki M (2004) A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster. Mol Cell Neurosci 26: 365-375 (Pubitemid 38968431)
Fluhrer R, Friedlein A, Haass C, Walter J (2004) Phosphorylation of presenilin 1 at the caspase recognition site regulates its proteolytic processing and the progression of apoptosis. J Biol Chem 279: 1585-1593 (Pubitemid 38084422)
Forman MS, Trojanowski JQ, Lee VM (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10: 1055-1063 (Pubitemid 39424865)
Gourine AV, Dale N, Llaudet E, Poputnikov DM, Spyer KM, Gourine VN (2007) Release of ATP in the central nervous system during systemic inflammation: real-time measure-ment in the hypothalamus of conscious rabbits. J Physiol 585: 305-316 (Pubitemid 350131122)
Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurode-generation: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112 (Pubitemid 46432529)
Harper JD, Lansbury Jr PT (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physio-logical consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66: 385-407 (Pubitemid 27274662)
Hori Y, Hashimoto T, Wakutani Y, Urakami K, Nakashima K, Condron MM, Tsubuki S, Saido TC, Teplow DB, Iwatsubo T (2007) The Tottori (D7N) and English (H6R) familial Alzheimer disease mutations accelerate Abeta fibril formation without in-creasing protofibril formation. J Biol Chem 282: 4916-4923 (Pubitemid 47100948)
Iijima K, Chiang HC, Hearn SA, Hakker I, Gatt A, Shenton C, Granger L, Leung A, Iijima-Ando K, Zhong Y (2008) Abeta42 mutants with different aggregation profiles induce distinct pathol-ogies in Drosophila. PLoS One 3: e1703
Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489 (Pubitemid 36444329)
Kennedy JL, Farrer LA, Andreasen NC, Mayeux R, George-Hyslop P (2003) The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science 302: 822-826 (Pubitemid 37339615)
Kim KS, Miller DL, Sapienza VJ, Chen C-M, Bai C, Grundke-IqbalI, Currie JR, Wisniewski HM (1988) Production and charac-terization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 2: 121-130
Kirkitadze MD, Condron MM, Teplow DB (2001) Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J Mol Biol 312: 1103-1119 (Pubitemid 32980329)
Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, Micheva KD, Smith SJ, Kim ML, Lee VM, Hyman BT, Spires-Jones TL (2009) Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA 106: 4012-4017
Kübler D, Pyerin W, Bill O, Hotz A, Sonka J, Kinzel V (1989) Evidence for ecto-protein kinase activity that phosphorylates Kemptide in a cyclic AMP-dependent mode. J Biol Chem 264: 14549-14555 (Pubitemid 19214292)
LeVine III H (2005) Mechanism of A beta(1-40) fibril-induced fluorescence of (trans,trans)-1-bromo-2,5-bis(4-hydroxystyryl)-benzene (K114). Biochemistry 44: 15937-15943
Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D (2009) Soluble oligomers of amyloid Beta protein facilitate hip-pocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62: 788-801
Luheshi LM, Tartaglia GG, Brorsson AC, Pawar AP, Watson IE, Chiti F, Vendruscolo M, Lomas DA, Dobson CM, Crowther DC (2007) Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity. PLoS Biol 5: e290
Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430: 631-639 (Pubitemid 39061671)
Melani A, Turchi D, Vannucchi MG, Cipriani S, Gianfriddo M, Pedata F (2005) ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem Int 47: 442-448 (Pubitemid 41242625)
Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313: 1781-1784 (Pubitemid 44454153)
Meyer-Luehmann M, Mielke M, Spires-Jones TL, Stoothoff W, Jones P, Bacskai BJ, Hyman BT (2009) A reporter of local dendritic translocation shows plaque-related loss of neural system function in APP-transgenic mice. JNeurosci 29: 12636-12640
Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de CA, Rozkalne A, Koenigsknecht-Talboo J, Holtzman DM, Bacskai BJ, Hyman BT (2008) Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 451: 720-724 (Pubitemid 351220570)
Murakami K, Irie K, Morimoto A, Ohigashi H, Shindo M, Nagao M, Shimizu T, Shirasawa T (2002) Synthesis, aggregation, neurotoxi-city, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23. Biochem Biophys Res Commun 294: 5-10 (Pubitemid 34687206)
Murakami K, Irie K, Morimoto A, Ohigashi H, Shindo M, Nagao M, Shimizu T, Shirasawa T (2003) Neurotoxicity and physicochem-ical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amy-loid angiopathy and Alzheimer's disease. J Biol Chem 278: 46179-46187 (Pubitemid 37432769)
Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Naslund J, Lannfelt L (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta proto-fibril formation. Nat Neurosci 4: 887-893 (Pubitemid 32801591)
Pedata F, Melani A, Pugliese AM, Coppi E, Cipriani S, Traini C (2007) The role of ATP and adenosine in the brain under normoxic and ischemic conditions. Purinergic Signal 3: 299-310
Redegeld FA, Caldwell CC, Sitkovsky MV (1999) Ecto-protein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation? Trends Pharmacol Sci 20: 453-459 (Pubitemid 29528217)
Rochet JC, Lansbury Jr PT (2000) Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10: 60-68 (Pubitemid 30099328)
Roher AE, Chaney MO, Kuo YM, Webster SD, Stine WB, Haverkamp LJ, Woods AS, Cotter RJ, Tuohy JM, Krafft GA, Bonnell BS, Emmerling MR (1996) Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem 271: 20631-20635 (Pubitemid 26281842)
Saido TC, Iwatsubo T, Mann DM, Shimada H, Ihara Y, Kawashima S (1995) Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. Neuron 14: 457-466
Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M, Kehlen A, Holzer M, Hutter-Paier B, Prokesch M, Windisch M, Jagla W Schlenzig D, Lindner C, Rudolph T, Reuter G, Cynis H, Montag D, Demuth HU, Rossner S (2008) Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology. Nat Med 14: 1106-1111
Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy Physiol Rev 81: 741-766 (Pubitemid 32267077)
Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192: 106-113
Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14: 837-842
Soto C, Estrada LD (2008) Protein misfolding and neurodegenera-tion. Arch Neurol 65: 184-189
Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, Bacskai BJ, Hyman BT (2005) Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton micro-scopy. J Neurosci 25: 7278-7287 (Pubitemid 41113944)
Spires-Jones TL, Meyer-Luehmann M, Osetek JD, Jones PB, Stern EA, Bacskai BJ, Hyman BT (2007) Impaired spine stability under-lies plaque-related spine loss in an Alzheimer's disease mouse model. Am J Pathol 171: 1304-1311 (Pubitemid 47582903)
Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120: 545-555 (Pubitemid 40269768)
Tomiyama T, Matsuyama S, Iso H, Umeda T, Takuma H, Ohnishi K, Ishibashi K, Teraoka R, Sakama N, Yamashita T, Nishitsuji K, Ito K, Shimada H, Lambert MP, Klein WL, Mori H (2010) A mouse model of amyloid {beta} oligomers: their con-tribution to synaptic alteration, abnormal tau phosphoryl-ation, glial activation, and neuronal loss in vivo. J Neurosci 30: 4845-4856
Tsai J, Grutzendler J, Duff K, Gan WB (2004) Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 7: 1181-1183 (Pubitemid 39426234)
Walker LC, Bian F, Callahan MJ, Lipinski WJ, Durham RA, LeVine H (2002) Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key? Amino Acids 23: 87-93
Walter J, Schnölzer M, Pyerin W, Kinzel V, Kübler D (1996) Induced release of ecto-protein kinase Yields CK-1 and CK-2 in tandem J Biol Chem 271: 111-119 (Pubitemid 26026565)
Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16: 921-932 (Pubitemid 26171198)